| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 06/03/2004 | WO2004046105A2 Synthesis of 3,5-dihydroxy-7-pyrrol-1-yl heptanoic acids |
| 06/03/2004 | WO2004046103A2 Arylpyridine compounds |
| 06/03/2004 | WO2004046101A2 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| 06/03/2004 | WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 06/03/2004 | WO2004045536A2 Method and compositions for temporarily incapaciting subjets |
| 06/03/2004 | WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | WO2004027046A3 Methods of producing 4-amino-3-mercapto-triazoles |
| 06/03/2004 | WO2004022542A3 Substituted 1,2,3,4-tetrahydroquinoline derivatives |
| 06/03/2004 | WO2004018419A3 Benzimidazole quinolinones and uses thereof |
| 06/03/2004 | WO2004014868A3 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 06/03/2004 | WO2004009549A3 Piperidines useful for the treatment of central nervous system disorders |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/03/2004 | US20040106792 Biphenyl compound |
| 06/03/2004 | US20040106676 Water-soluble etoposide analogs and methods of use thereof |
| 06/03/2004 | US20040106667 novel specific indazoles exhibiting anticancer activity via the modulation of the activity of proteins, in particular of kinases |
| 06/03/2004 | US20040106664 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 06/03/2004 | US20040106659 hydantoin, oxazoledione and thiazoledione (or dithiione) derivatives; e.g., 5-[1-(Biphenyl-4-yloxy)-ethyl]-5-methyl-imidazolidine-2,4-dione |
| 06/03/2004 | US20040106645 Antagonists of melanin concentrating hormone receptor |
| 06/03/2004 | US20040106634 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 06/03/2004 | US20040106627 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 06/03/2004 | US20040106621 3-Heterocyclic benzylamide derivatives as potassium channel openers |
| 06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 06/03/2004 | US20040106615 For treating or lessening the severity of a variety of disorders, including stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant |
| 06/03/2004 | US20040106612 Selective inhibitor of cyclooxygenase-2 used as an antipyretic, an analgesic, and an antiinflammatory agent, with reduced side effects. |
| 06/03/2004 | US20040106608 Novel imidazole compounds as transforming growth factor (TGF) inhibitors |
| 06/03/2004 | US20040106606 Dihydropyrones with tethered heterocycles |
| 06/03/2004 | US20040106600 N-substituted piperidine derivatives as serotonin receptor agents |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | US20040106595 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof |
| 06/03/2004 | US20040106581 Inhibitors of cyclin-dependent kinases and their use |
| 06/03/2004 | US20040106521 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 06/03/2004 | US20040106519 Herbicidal composition |
| 06/03/2004 | DE10254092A1 New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer |
| 06/03/2004 | CA2518917A1 Pyridazinone derivatives as cdk2-inhibitors |
| 06/03/2004 | CA2506735A1 Indole derivatives as somatostatin agonists or antagonists |
| 06/03/2004 | CA2506503A1 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| 06/03/2004 | CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication |
| 06/03/2004 | CA2506297A1 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors |
| 06/03/2004 | CA2506112A1 Substituted aralkyl derivatives |
| 06/03/2004 | CA2506025A1 Amino-heterocycles as vr-1 antagonists for treating pain |
| 06/03/2004 | CA2506022A1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 06/03/2004 | CA2505789A1 Diaminotriazoles useful as inhibitors of protein kinases |
| 06/03/2004 | CA2503316A1 Method and compositions for temporarily incapacitating subjects |
| 06/03/2004 | CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/02/2004 | EP1424335A1 Indole derivatives |
| 06/02/2004 | EP1424325A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 06/02/2004 | EP1423384A1 Pyridine derivatives as raf kinase inhibitors |
| 06/02/2004 | EP1423383A1 Pyridine substituted furan derivatives as raf kinase inhibitors |
| 06/02/2004 | EP1423381A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 06/02/2004 | EP1423380A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 06/02/2004 | EP1423376A1 Bicyclic compound, production and use thereof |
| 06/02/2004 | EP1423375A2 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof |
| 06/02/2004 | EP1423373A2 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 06/02/2004 | EP1423372A2 Triazine compounds, polymers comprising triazine structural units, and processes for the preparation of these polymers |
| 06/02/2004 | EP1423371A1 Triazine derivatives and their use as sunscreens |
| 06/02/2004 | EP1423366A1 Cyclopenta b ! indole derivatives as spla2 inhibitors |
| 06/02/2004 | EP1423365A1 Process for the preparation of indole derivatives |
| 06/02/2004 | EP1423120A1 2h-phthalazin-1-ones and methods for use thereof |
| 06/02/2004 | EP1423110A2 Cbi analogues of cc-1065 and the duocarmycins |
| 06/02/2004 | EP1423107A2 Fatty alcohol drug conjugates |
| 06/02/2004 | EP1423006A1 Agonists and antagonists of 5h 3?-like receptors of invertebrate s as pesticides |
| 06/02/2004 | EP1182202B1 Aminomethylpyrrolidine derivatives having aromatic substituents |
| 06/02/2004 | CN1501939A Crystal of pyrimidine nucleoside derivative |
| 06/02/2004 | CN1501915A Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 06/02/2004 | CN1152032C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 06/02/2004 | CN1152031C Isoquinoline derivatives with angiogenesis inhibiting activity |
| 06/02/2004 | CN1152022C Alpha-substituted. pyrimidine-thioalkyl and alkyl ether compounds |
| 06/02/2004 | CN1152021C Intermediate for preparing corticotropin release factors antagonistic agent and preparing method thereof |
| 06/02/2004 | CN1152014C N-aryl anthranilic acid derivatives and uses thereof |
| 06/01/2004 | US6743910 Stereoselective synthesis of nucleoside analogues |
| 06/01/2004 | US6743816 Imidazole derivatives with anti-inflammatory activity |
| 06/01/2004 | US6743809 Indole Derivatives useful for the treatment of CNS disorders |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743805 Treating vascular proliferative disorders |
| 06/01/2004 | US6743804 Quinoline derivatives as NK3 antagonists |
| 06/01/2004 | US6743793 Dp receptor antagonist; prostaglandin d |
| 06/01/2004 | US6743791 Heterocyclic inhibitors of ERK2 and uses thereof |
| 06/01/2004 | US6743788 Carbamate and oxamide compounds |
| 06/01/2004 | US6743755 Substituted N-aryl nitrogen-containing heterocyclic compounds |
| 06/01/2004 | CA2266016C Tricyclic inhibitors of farnesyl protein transferase |
| 06/01/2004 | CA2146646C Benzopyranones, method of preparing them and their use |
| 05/29/2004 | WO2004035566A1 Cannabinoid receptor ligands and uses thereof |
| 05/29/2004 | CA2502511A1 Cannabinoid receptor ligands and uses thereof |
| 05/27/2004 | WO2004043954A2 Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same |
| 05/27/2004 | WO2004043950A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 05/27/2004 | WO2004043943A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/27/2004 | WO2004043937A1 Quinoxaline derivative, organic semiconductor device and electroluminescent element |
| 05/27/2004 | WO2004043936A1 Plk inhibitors |
| 05/27/2004 | WO2004043927A1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials |
| 05/27/2004 | WO2004043926A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| 05/27/2004 | WO2004043925A2 3-substituted-6-aryl pyridined as ligands of c5a receptors |
| 05/27/2004 | WO2004043918A2 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 05/27/2004 | WO2004043884A2 Novel acylating reagents |
| 05/27/2004 | WO2004043458A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/27/2004 | WO2004043392A2 Mucin synthesis inhibitors |
| 05/27/2004 | WO2004043389A2 Methods of treating cancer and related methods |
| 05/27/2004 | WO2004043366A2 Sulfonamides |
| 05/27/2004 | WO2004032908A9 Method of inhibiting angiogenesis |
| 05/27/2004 | WO2004031160A3 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes |